Author

Vanessa Marensi

Observed names: Marensi, Vanessa, V. Marensi

Institutions: University of Liverpool, Bangor University

Observed institutions: University of Chester, University of Liverpool, University of Alberta, Bangor University, Queen's University, Universidade do Vale do Itajaí

ORCID: 0000-0002-4898-194X

Observed ORCID: 0000-0002-4898-194X

OpenAlex ID: A5063256548

Ethnopharmacognostic survey on botanical compendia for potential cosmeceutic species from Atlantic Forest

2007 · Maique W. Biavatti, Vanessa Marensi, et al. · Revista Brasileira de Farmacognosia · 76

Polymorphic variants of MRP4/ABCC4 differentially modulate the transport of methylated arsenic metabolites and physiological organic anions

2016 · Mayukh Banerjee, Vanessa Marensi, et al. · Biochemical Pharmacology · 41

Arsenic Triglutathione [As(GS)3] Transport by Multidrug Resistance Protein 1 (MRP1/ABCC1) Is Selectively Modified by Phosphorylation of Tyr920/Ser921 and Glycosylation of Asn19/Asn23

2016 · Caley B. Shukalek, Diane P. Swanlund, et al. · Molecular Pharmacology · 26

Pharmacological impact of FLT3 mutations on receptor activity and responsiveness to tyrosine kinase inhibitors

2020 · Vanessa Marensi, Karen R. Keeshan, et al. · Biochemical Pharmacology · 23

Evolutionary and cellular analysis of the ‘dark’ pseudokinase PSKH2

2022 · Dominic P. Byrne, Safal Shrestha, et al. · Biochemical Journal · 6

Determining site occupancy of acetaminophen covalent binding to target proteins in vitro

2021 · Timon Geib, Cristina Lento, et al. · Analytical Science Advances · 6

Glutathione transferase P1 is modified by palmitate

2024 · Vanessa Marensi, Megan C. Yap, et al. · PLoS ONE · 3

Redox, cysteines, and kinases—A triad sustaining myeloid leukemia

2024 · Vanessa Marensi · Advances in cancer research · 3

Editorial: Targeting cellular signalling pathways for disease therapy: the potential of cellular reprogramming and protein kinase inhibitors

2025 · Vanessa Marensi, Pedro Fontes Oliveira, et al. · Frontiers in Pharmacology · 2

Mediating kinase activity in Ras-mutant cancer: potential for an individualised approach?

2024 · Fiona M. Healy, Amy L. Turner, et al. · Frontiers in Pharmacology · 1

In search of a targetable immune profile for acute myeloid leukemia

2025 · Gurnit Kaur, Negar Ghaffari, et al. · Advances in cancer research

P408: Nras Mutations Are Involved in Acute Myeloid Leukaemia Drug Resistance

2022 · F. Healy, V. Marensi, et al. · HemaSphere

Glutathione Transferase P1 is Modified by Palmitate

2017 · Marensi, Vanessa · ERA: Education and Research Archive (University of Alberta)

Glutathione Transferase P1 (GSTP1) is Modified by Palmitate

2016 · Vanessa Marensi, Megan Yap, et al. · The FASEB Journal

Works count: 14

Citation count: 187

H-index: 6

I10-index: 4